Tiny tools closing the gap: nanobodies in research and therapy

Area of Science:

• Biotechnology and Immunology
• Molecular Biology

Background:

• Nanobodies are single-domain antibody fragments derived from camelid heavy-chain-only antibodies.
• They are approximately 10 times smaller than conventional antibodies, retaining key binding characteristics.
• Recent advancements include novel discovery methods and in vitro evolution for enhanced specificity and avidity.

Purpose of the Study:

• To review the latest developments in nanobody technology.
• To discuss the diverse applications of nanobodies in bioimaging, therapy, and intracellular protein studies.

Main Methods:

• Exploration of conventional and synthetic nanobody repertoires for discovery.
• Utilizing mutation and selection cycles to optimize nanobody binding properties.
• Review of existing literature on nanobody applications in various fields.

Main Results:

• Nanobodies exhibit enhanced tissue penetration and access to cryptic sites due to their small size.
• Their minimal size reduces linkage errors for fluorophore conjugation, ideal for high-resolution imaging.
• Stable intracellular expression allows for detailed study of protein function in native cellular contexts.

Conclusions:

• Nanobodies are versatile tools with significant potential in therapeutic and diagnostic applications.
• Their unique characteristics facilitate advanced bioimaging and the investigation of intracellular targets.
• Continued development promises expanded utility in biomedical research and clinical practice.